You have 9 free searches left this month | for more free features.

City

Antwerp (1)

Haskovo (1)

Leeds (1)

Stara Zagora (1)

Condition

Chronic Obstructive Pulmonary Disease (4)

Uncontrolled Asthma (1)

Overall Status

Completed (2)

Recruiting (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 3 (2)

phase 2 (1)

Sponsor

Chiesi Farmaceutici S.p.A. (5)

Collaborator

Study Documents

Intervention Type

drug (5)

Funder Type

Industry (5)

Study Type

Interventional (5)

Tanimilast

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Uncontrolled Asthma Trial (Experimental: CHF6001 3200 µg, Placebo Comparator: CHF6001 Placebo)

Not yet recruiting

Uncontrolled Asthma

Experimental: CHF6001 3200 μg
Placebo Comparator: CHF6001 Placebo

(no location specified)

Sep 7, 2023

COPD Trial in Haskovo (Experimental: CHF6001 1600µg, Experimental: CHF6001 3200µg, Placebo)

Recruiting

Chronic Obstructive Pulmonary Disease

Experimental: CHF6001 1600µg
+2 more

Haskovo, Bulgaria

Chiesi Clinical Trial - Site 100423

Mar 8, 2022

COPD Trial in Leeds (CHF6001)

Completed

Chronic Obstructive Pulmonary Disease

CHF6001

Leeds, United Kingdom

Covance - Clinical Research Unit

May 4, 2021

COPD Trial in Antwerp (CHF6001 DPI, Itraconazole)

Completed

Chronic Obstructive Pulmonary Disease

CHF6001 DPI
Itraconazole

Antwerp, Belgium

SGS Life Sciences - Clinical Pharmacology Unit Antwerpen

May 4, 2021

COPD Trial in Stara Zagora (CHF6001 1600µg, CHF6001 3200µg, Placebo)

Recruiting

Chronic Obstructive Pulmonary Disease

CHF6001 1600µg
+3 more

Stara Zagora, Bulgaria

Site 100524 - Medical Centre New Rehabilitation Centre EOOD

Jul 27, 2021